Search
Descriptor English: Sulfasalazine
Descriptor Spanish: Sulfasalazina
Descriptor sulfasalazina
Entry term(s) salicilazosulfapiridina
Scope note: Fármaco utilizado en el tratamiento de la enfermedad inflamatoria intestinal. Se considera que su actividad se basa en su producto de degradación metabólica, el ácido 5-aminosalicílico (ver MESALAMINA) liberado en el colon. (Martindale, The Extra Pharmacopoeia, 30th ed, p907)
Descriptor Portuguese: Sulfassalazina
Descriptor French: Sulfasalazine
Entry term(s): Asulfidine
Azulfadine
Azulfidine
Azulfidine EN
Colo Pleon
Colo-Pleon
Pleon
Pyralin EN
Salazopyrin
Salazosulfapyridine
Salicylazosulfapyridine
Sulfasalazin Heyl
Sulfasalazin medac
Sulfasalazin-Heyl
Sulfasalazine FNA
Sulphasalazine
Ucine
Ulcol
ratio Sulfasalazine
ratio-Sulfasalazine
Tree number(s): D02.065.884.730
D02.886.590.700.730
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D012460
Scope note: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Infective Agents
Anti-Inflammatory Agents, Non-Steroidal
Gastrointestinal Agents
Antirheumatic Agents
Registry Number: 3XC8GUZ6CB
CAS Type 1 Name: Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-
Public MeSH Note: 1995; see SALICYLAZOSULFAPYRIDINE 1963-1994; for SULFASALAZINE see SALICYLAZOSULFAPYRIDINE 1975-1994
History Note: 1995 (1963)
DeCS ID: 12835
Unique ID: D012460
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1995/01/01
Date of Entry: 1999/01/01
Revision Date: 2018/03/01
Sulfasalazine - Preferred
Concept UI M0019365
Scope note A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
Preferred term Sulfasalazine
Entry term(s) Salazosulfapyridine
Salicylazosulfapyridine
Sulphasalazine
Pyralin EN - Narrower
Concept UI M000623477
Preferred term Pyralin EN
Azulfadine - Narrower
Concept UI M0019367
Preferred term Azulfadine
Entry term(s) Asulfidine
Azulfidine
Azulfidine EN
Colo-Pleon - Narrower
Concept UI M0475928
Preferred term Colo-Pleon
Entry term(s) Colo Pleon
Pleon
Ulcol - Narrower
Concept UI M0475941
Preferred term Ulcol
Sulfasalazin medac - Narrower
Concept UI M0475937
Preferred term Sulfasalazin medac
Sulfasalazin-Heyl - Narrower
Concept UI M0475938
Preferred term Sulfasalazin-Heyl
Entry term(s) Sulfasalazin Heyl
Sulfasalazine FNA - Narrower
Concept UI M0475939
Preferred term Sulfasalazine FNA
Ucine - Narrower
Concept UI M0475940
Preferred term Ucine
Salazopyrin - Narrower
Concept UI M000623478
Preferred term Salazopyrin
ratio-Sulfasalazine - Narrower
Concept UI M0475936
Preferred term ratio-Sulfasalazine
Entry term(s) ratio Sulfasalazine



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey